Histamine differentially regulates the production of Th1 and Th2 chemokines by keratinocytes through histamine H1 receptor

Cytokine

Volumn 54, Issue 2, 2011, Pages 191-199

  Fujimoto, Seiki ^a,b   Komine, Mayumi ^a,c   Karakawa, Masaru ^a   Uratsuji, Hideya ^a,b   Kagami, Shinji ^a   Tada, Yayoi ^a   Saeki, Hidehisa ^a   Ohtsuki, Mamitaro ^c   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Maruho Company Ltd   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

H1R; Histamine; Keratinocytes; Th1; Th2

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; STAT1 PROTEIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ARTICLE; CHEMOKINESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALE; NEGATIVE FEEDBACK; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; UPREGULATION;

BASE SEQUENCE; CELL LINE; CHEMOKINES; DNA PRIMERS; HISTAMINE; HUMANS; KERATINOCYTES; PROTEIN KINASES; RECEPTORS, HISTAMINE H1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH1 CELLS; TH2 CELLS;

EID: 79953034076     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.12.012     Document Type: Article

References (42)

1. Hill S.J., Ganellin C.R., Timmerman H., Schwartz J.C., Shankley N.P., Young J.M., et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 1997, 49:253-278.
2. Metcalfe D.D., Baram D., Mekori Y.A. Mast cells. Physiol Rev 1997, 77:1033-1079.
3. Oda T., Morikawa N., Saito Y., Masuho Y., Matsumoto S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 2000, 275:36781-36786.
4. Matsumoto T., Kanaide H., Nishimura J., Shogakiuchi Y., Kobayashi S., Nakamura M. Histamine activates H1-receptors to induce cytosolic free calcium transients in cultured vascular smooth muscle cells from rat aorta. Biochem Biophys Res Commun 1986, 135:172-177.
5. Kotlikoff M.I., Murray R.K., Reynolds E.E. Histamine-induced calcium release and phorbol antagonism in cultured airway smooth muscle cells. Am J Physiol 1987, 253:C561-C566.
6. 2+ concentration in bovine tracheal smooth muscle using aequorin. Am J Physiol 1987, 253:C817-C827.
7. Panettieri R.A., Murray R.K., DePalo L.R., Yadvish P.A., Kotlikoff M.I. A human airway smooth muscle cell line that retains physiological responsiveness. Am J Physiol 1989, 256:C329-C335.
8. Shiraishi M., Hirasawa N., Oikawa S., Kobayashi Y., Ohuchi K. Analysis of histamine-producing cells at the late phase of allergic inflammation in rats. Immunology 2000, 99:600-606.
9. Hanifin J.M. Atopic dermatitis. J Allergy Clin Immunol 1984, 73:211-226.
10. Mihm M.C., Soter N.A., Dvorak H.F., Austen K.F. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976, 67:305-312.
11. Ring J., Thomas P. Histamine and atopic eczema. Acta Derm Venereol Suppl (Stockh) 1989, 144:70-77.
12. Kohda F., Koga T., Uchi H., Urabe K., Furue M. Histamine-induced IL-6 and IL-8 production are differentially modulated by IFN-γ and IL-4 in human keratinocytes. J Dermatol Sci 2002, 28:34-41.
13. Kanda N., Watanabe S. Histamine enhances the production of granulocyte-macrophage colony-stimulating factor via protein kinase Calpha and extracellular signal-regulated kinase in human keratinocytes. J Invest Dermatol 2004, 122:863-872.
14. Kanda N., Watanabe S. Histamine inhibits the production of interferon-induced protein of 10kDa in human squamous cell carcinoma and melanoma. J Invest Dermatol 2002, 119:1411-1419.
15. Imai T., Nagira M., Takagi S., Kakizaki M., Nishimura M., Wang J., et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999, 11:81-88.
16. Bonecchi R., Bianchi G., Bordignon P.P., D'Ambrosio D., Lang R., Borsatti A., et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998, 187:129-134.
17. Sallusto F., Lenig D., Mackay C.R., Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998, 187:875-883.
18. Kakinuma T., Nakamura K., Wakugawa M., Mitsui H., Tada Y., Saeki H., et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001, 107:535-541.
19. Fujisawa T., Fujisawa R., Kato Y., Nakayama T., Morita A., Katsumata H., et al. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 2002, 110:139-146.
20. Kakinuma T., Wakugawa M., Nakamura K., Hino H., Matsushima K., Tamaki K. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid. Br J Dermatol 2003, 148:203-210.
21. Kakinuma T., Sugaya M., Nakamura K., Kaneko F., Wakugawa M., Matsushima K., et al. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: Serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 2003, 48:23-30.
22. Saeki H., Tamaki K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 2006, 43:75-84.
23. Giustizieri M.L., Albanesi C., Fluhr J., Gisondi P., Norgauer J., Girolomoni G. H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 2004, 114:1176-1182.
24. Shinoda S., Kameyoshi Y., Hide M., Morita E., Yamamoto S. Histamine enhances UVB-induced IL-6 production by human keratinocytes. Arch Dermatol Res 1998, 290:429-434.
25. 2+-dependent protein kinase C, Raf/MEK/ERK and IKK/IκB/NF-κB signal cascades. Biochem Pharmacol 2005, 69:433-449.
26. Cannon K.E., Chazot P.L., Hann V., Shenton F., Hough L.B., Rice F.L. Immunohistochemical localization of histamine H3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia, and spinal cord: potential antinociceptive targets. Pain 2007, 129:76-92.
27. Greaves M.W., Sabroe R.A. Histamine: the quintessential mediator. J Dermatol 1996, 23:735-740.
28. Jujo K., Renz H., Abe J., Gelfand E.W., Leung D.Y. Decreased interferon-γ and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol 1992, 90:323-331.
29. Kagi M.K., Wuthrich B., Montano E., Barandun J., Blaser K., Walker C. Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals. Int Arch Allergy Immunol 1994, 103:332-340.
30. Werfel T., Morita A., Grewe M., Renz H., Wahn U., Krutmann J., et al. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol 1996, 107:871-876.
31. Komine M., Kakinuma T., Kagami S., Hanakawa Y., Hashimoto K., Tamaki K. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J Invest Dermatol 2005, 125:491-498.
32. Tsuda T., Tohyama M., Yamasaki K., Shirakata Y., Yahata Y., Tokumaru S., et al. Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro. J Dermatol Sci 2003, 31:37-42.
33. Nakayama T., Hieshima K., Nagakubo D., Sato E., Nakayama M., Kawa K., et al. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J Virol 2004, 78:1665-1674.
34. Kanda N., Watanabe S. Prolactin enhances interferon-γ-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 2007, 148:2317-2325.
35. Osna N., Elliott K., Chaika O., Patterson E., Lewis R.E., Khan M.M. Histamine utilizes JAK-STAT pathway in regulating cytokine production. Int Immunopharmacol 2001, 1:759-762.
36. Sakhalkar S.P., Patterson E.B., Khan M.M. Involvement of histamine H1 and H2 receptors in the regulation of STAT-1 phosphorylation: inverse agonism exhibited by the receptor antagonists. Int Immunopharmacol 2005, 5:1299-1309.
37. Kanda N., Watanabe S. Histamine enhances the production of human β-defensin-2 in human keratinocytes. Am J Physiol Cell Physiol 2007, 293:C1916-C1923.
38. Jutel M., Klunker S., Akdis M., Małolepszy J., Thomet O.A., Zak-Nejmark T., et al. Histamine upregulates Th1 and downregulates Th2 responses due to different patterns of surface histamine 1 and 2 receptor expression. Int Arch Allergy Immunol 2001, 124:190-192.
39. Jutel M., Watanabe T., Klunker S., Akdis M., Thomet O.A., Malolepszy J., et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001, 413:420-425.
40. Elenkov I.J., Webster E., Papanicolaou D.A., Fleisher T.A., Chrousos G.P., Wilder R.L. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 1998, 161:2586-2593.
41. Mazzoni A., Young H.A., Spitzer J.H., Visintin A., Segal D.M. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 2001, 108:1865-1873.
42. Kakinuma T., Nakamura K., Wakugawa M., Yano S., Saeki H., Torii H., et al. IL-4, but not IL-13, modulates TARC (thymus and activation-regulated chemokine)/CCL17 and IP-10 (interferon-induced protein of 10kDA)/CXCL10 release by TNF-α and IFN-γ in HaCaT cell line. Cytokine 2002, 20:1-6.